This interdisciplinary conference addresses the knowledge continuum from molecular structure and fundamental mechanisms to biological, energy production, and medical applications, focusing on new approaches to imaging, manipulation, and analysis of biomolecules, cells and tissues, both in vitro and in vivo. The conference will report on the latest developments in functional and multispectral imaging, optogenetics, analysis, algorithms, quantification, separation, sorting, and standards for cells and tissues. The principal aim is to further improve the interdisciplinary dialogue between those who design and implement critical technologies and the primary users who study important problems that drive developments, in order to advance translational research.

Reports of original research contributions are solicited on the following topics: ;
In progress – view active session
Conference BO500

Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XXI

This conference has an open call for papers:
Abstract Due: 20 July 2022
Author Notification: 10 October 2022
Manuscript Due: 11 January 2023
This interdisciplinary conference addresses the knowledge continuum from molecular structure and fundamental mechanisms to biological, energy production, and medical applications, focusing on new approaches to imaging, manipulation, and analysis of biomolecules, cells and tissues, both in vitro and in vivo. The conference will report on the latest developments in functional and multispectral imaging, optogenetics, analysis, algorithms, quantification, separation, sorting, and standards for cells and tissues. The principal aim is to further improve the interdisciplinary dialogue between those who design and implement critical technologies and the primary users who study important problems that drive developments, in order to advance translational research.

Reports of original research contributions are solicited on the following topics:
    Functional imaging of biomolecules, live cells and tissues:
    • light including time-lapse microscopy of living cells and tissues (2D, 3D, 4D)
    • spectral and multiphoton imaging of multiple cellular and tissue components
    • side, orthogonal, or other angles illumination
    • new and automated methods for monitoring biological structure, the effects of pharmaceuticals, and physiology
    • microscopic imaging of electric potentials and events
    • mesoscopic (microscopic resolution in vivo) tissue imaging
    • multimode and multimodality tissue imaging in vivo.
    Biophotonic techniques for regenerative medicine:
    • stem cell characterization in vitro
    • stem cell imaging and tracking in vivo
    • in vivo studies of immunologic events
    • imaging methods in organ transplantation and graft monitoring
    • creation and functional monitoring of tissue engineering constructs
    • imaging of tissue oxygenation and vascularization.
    Optical manipulation of cells and tissues:
    • cell micromanipulation using optical trapping (laser tweezers)
    • cellular effects of localized energy deposition into micro- and nano-absorbers
    • cells and biomolecules in micro- and nano-confined spaces
    • scanning probe microscopy of cells and surface-immobilized biomolecules.
    Spectral imaging and multiparameter measurements (microscopic and macroscopic):
    • spectral pathology and endoscopy
    • digital imaging and holography for quantitative tissue and cellular pathology
    • small animal imaging
    • bioenergy applications
    • food quality, food defense and food safety applications
    • forensic applications
    • tools and approaches for combining optical and other measurements
    • tools and approaches for combining several optical imaging methods
    • advanced registration and visualization, and cell architecture studies.
    Advanced quantitative cell (Cytomics) and tissue (Histomics) analysis:
    • fluorescence and luminescence imaging including lifetime and two-photon imaging
    • Raman, refractive index, polarization, isotope, ultrasonic, photo-acoustic and other modalities based imaging instrumentation and technology
    • probes, including new dyes, mass (isotopes) tags, bioluminescence, and the presence of oxygen
    • nanoparticle based imaging
    • imaging in flow of cells
    • light-scattering, dark field and light-sheet based imaging
    • lens-free microscopy
    • high-throughput cytometry
    • whole slide imaging
    • in situ diagnostic applications
    • technologies for multispectral and multiparameter imaging, including acquisition, autofluorescence reduction, segmentation and analysis methods
    • new components for cytometry instrumentation, including ultraminiature and nano- systems
    • clinical and research applications of cytometry, with emphasis on new and unusual approaches
    • new methods for cell separation including high-speed, optical and magnetic-paramagnetic sorting
    • rare event detection
    • circulating stem, fetal, cancer, colony forming and other rare cells
    • mutant selection
    • medical problems in need of advanced quantitative cell or tissue analysis
    • quality control and other demonstrations of the reliability and quality of measurements
    • Microarrays for biomolecules, cells, three-dimensional (3D) cultures (spheroids) and tissues
    • printing technologies
    • readout methods, including image analysis and quantification
    • applications of microarrays in diagnostics and drug discovery.
    Bioinformatics, image and data processing, quantification, standards, and display methods:
    • cell-based high-throughput and high-content screening clustering algorithms
    • analytical quantification, including new methods for multiparameter cell and tissue analysis and data manipulation including the application of chemometric analysis techniques
    • automated 3D image processing, including tracking of tissue section surfaces, image segmentation, and fluorimetry/densitometry
    • software standards including those based upon the web, scientific and/or medical organizations and/or societies and regulatory requirements for spectroscopy, flow cytometry, and digital imaging including pathology
    • software for quality control including reproducibility
    • image formats, databasing, and retrieval
    • advanced image registration and display, including co-display of multimodality image sets
    • whole slide imaging.
    Monitoring of pilot and industrial cell and tissue growth and production for:
    • biomedical products applications
    • tissue engineering
    • energy applications.
Conference Chair
Univ. Leipzig (Germany)
Conference Chair
New Mexico State Univ. (United States)
Conference Co-Chair
Purdue Univ. (United States)
Program Committee
Univ. of California, Davis (United States)
Program Committee
Northwestern Univ. (United States)
Program Committee
The Univ. of Texas at Austin (United States)
Program Committee
Beckman Institute for Advanced Science and Technology (United States)
Program Committee
Christopher H. Contag
Michigan State Univ. (United States)
Program Committee
Univ. of St. Andrews (United Kingdom)
Program Committee
Imperial College London (United Kingdom)
Program Committee
Bar-Ilan Univ. (Israel)
Program Committee
The Univ. of Tokyo (Japan)
Program Committee
Jet Propulsion Lab. (United States)
Program Committee
Bo Huang
Univ. of California, San Francisco (United States)
Program Committee
Daegu Gyeongbuk Institute of Science & Technology (Korea, Republic of)
Program Committee
Massachusetts General Hospital (United States)
Program Committee
Charles P. Lin
Wellman Ctr. for Photomedicine (United States)
Program Committee
Mauna Kea Technologies (France)
Program Committee
Univ. of Michigan (United States)
Program Committee
U.S. Food and Drug Administration (United States)
Program Committee
Leica Microsystems CMS GmbH (Germany)
Program Committee
Foundation for Research and Technology-Hellas (Greece)
Program Committee
McGill Univ. (Canada)
Program Committee
Privolzhsky Research Medical Univ. (Russian Federation)
Additional Information
What you will need to submit
  • Title
  • Author(s) information
  • Speaker biography
  • 250-word abstract for technical review
  • 100-word summary for the program
  • Keywords used in search for your paper (optional)
Note: Only original material should be submitted. Commercial papers, papers with no new research/development content, and papers with proprietary restrictions will not be accepted for presentation.